The Pharma Letter examines how Foundayo could set itself apart as a pill for weight loss and glycemic control.
Recap by typeshit. Full story at The Pharma Letter.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
A Mayo Clinic Florida study of over 3,800 women found 9.8% vs 8.2% weight loss at 9 months with HT on semaglutide. Researchers say it shows association, not cause.
Stanford doctors look at what peptides are and whether the online wellness hype holds up, covering possible upsides alongside the risks.
His GLP-1 series turns to heart failure with preserved ejection fraction, where the heart pumps normally but struggles to relax and fill.
The hospital says tirzepatide may help with weight when medically appropriate but calls it no shortcut, urging people to understand the risks first.
TCTMD looks at the TRIUMPH-2 and SYNCHRONIZE-2 results in people with diabetes, where both new drugs worked well but left some open questions.
Loading…